BRÈVE

sur Cheplapharm Arzneimittel GmbH (isin : DE000CHP2222)

Sebastian Braun Honored as EY Entrepreneur of the Year

Sebastian Braun, Chairman and co-owner of CHEPLAPHARM, has been awarded the EY Entrepreneur of the Year in the ‘family business’ category. This accolade marks the first time a representative from eastern Germany has won since 2014. Presented globally in 60 countries, this award is one of the most esteemed in the business sector.

Under Braun's leadership, CHEPLAPHARM transitioned from a small enterprise to a global leader in the off-patent branded medicines market, achieving a turnover of 1.5 billion euros in 2023. The company, employing 750 people across multiple countries, ensures the provision of critical medicines internationally.

Braun attributes his success to a blend of preparation and opportunity, which resonated with the award's selection criteria: Entrepreneurship, Purpose, Growth, and Impact. As the eastern German pioneer, he expresses pride in his team’s role in this achievement.

R. H.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Cheplapharm Arzneimittel GmbH